Literature DB >> 12049884

Choosing the method to match the perspective: economic assessment and its implications for health-services efficiency.

Adam Oliver1, Andrew Healey, Cam Donaldson.   

Abstract

Mesh：

Year:  2002        PMID： 12049884     DOI： 10.1016/S0140-6736(02)08664-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?

Authors:  Suzanne Hill; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 2.  Prognosis without treatment as a modifier in health economic assessments.

Authors:  Ross Camidge; Andrew Walker; James J Oliver; Fiona Nussey; Simon Maxwell; Duncan Jodrell; David J Webb
Journal:  BMJ       Date:  2005-06-11

3.  Using discrete choice experiments within a cost-benefit analysis framework: some considerations.

Authors:  Emma McIntosh
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 4.  Bias in published cost effectiveness studies: systematic review.

Authors:  Chaim M Bell; David R Urbach; Joel G Ray; Ahmed Bayoumi; Allison B Rosen; Dan Greenberg; Peter J Neumann
Journal:  BMJ       Date:  2006-02-22

5.  The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.

Authors:  Sinaa A Al Aqeel; Mohammed Al-Sultan
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

6.  Effectiveness and costs of phototest in dementia and cognitive impairment screening.

Authors:  Cristobal Carnero-Pardo; Beatriz Espejo-Martinez; Samuel Lopez-Alcalde; Maria Espinosa-Garcia; Carmen Saez-Zea; Rosa Vilchez-Carrillo; Elisa Hernandez-Torres; Jose L Navarro-Espigares
Journal:  BMC Neurol       Date:  2011-07-29       Impact factor: 2.474

7.  Scoring the Icecap-a capability instrument. Estimation of a UK general population tariff.

Authors:  Terry N Flynn; Elisabeth Huynh; Tim J Peters; Hareth Al-Janabi; Sam Clemens; Alison Moody; Joanna Coast
Journal:  Health Econ       Date:  2013-11-20       Impact factor: 3.046

8.  Using Economic Evaluation to Hasten Health Equity.

Authors:  Maria Isabel Roldós; Nancy Breen
Journal:  Health Equity       Date:  2021-09-15

9.  Patient Willingness to Pay for Faster Return to Work or Smaller Incisions.

Authors:  Aaron Alokozai; Sarah E Lindsay; Sara L Eppler; Paige M Fox; Amy L Ladd; Robin N Kamal
Journal:  Hand (N Y)       Date:  2019-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.